$ACU
ACME UNITED CORP

2024 Q1 Form 10-K Financial Statement

#000095017024027907 Filed on March 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $44.96M $41.94M $191.5M
YoY Change -1.92% -4.92% -1.27%
Cost Of Revenue $27.56M $25.54M $119.3M
YoY Change -6.76% -14.95% -8.52%
Gross Profit $17.40M $16.40M $72.21M
YoY Change 6.85% 16.47% 13.61%
Gross Profit Margin 38.7% 39.11% 37.71%
Selling, General & Admin $14.84M $14.31M $59.02M
YoY Change 5.29% 1.43% 3.03%
% of Gross Profit 85.3% 87.24% 81.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $860.0K $1.336M $2.957M
YoY Change 19.44% 4.85% 7.03%
% of Gross Profit 4.94% 8.14% 4.09%
Operating Expenses $14.84M $14.31M $59.02M
YoY Change 5.29% 1.43% 3.03%
Operating Profit $2.558M $2.093M $13.19M
YoY Change 16.91% -8242.49% 110.24%
Interest Expense -$443.0K -$460.2K -$2.938M
YoY Change -50.89% -50.06% 41.49%
% of Operating Profit -17.32% -21.99% -22.27%
Other Income/Expense, Net $44.00K -$12.58M $12.52M
YoY Change -105.01% -11794.25% -5182.53%
Pretax Income $2.159M $14.16M $22.73M
YoY Change 64.94% -1787.15% 520.82%
Income Tax $523.0K $2.957M $4.941M
% Of Pretax Income 24.22% 20.88% 21.74%
Net Earnings $1.636M $11.21M $17.79M
YoY Change 65.25% -1976.52% 486.31%
Net Earnings / Revenue 3.64% 26.72% 9.29%
Basic Earnings Per Share $0.45 $4.98
Diluted Earnings Per Share $0.39 $2.92 $4.86
COMMON SHARES
Basic Shares Outstanding 3.645M 3.585M 3.572M
Diluted Shares Outstanding 4.213M 3.658M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.443M $4.796M $4.796M
YoY Change -11.61% -21.38% -21.38%
Cash & Equivalents $2.443M $4.796M $4.796M
Short-Term Investments
Other Short-Term Assets $6.110M $5.523M $5.523M
YoY Change 23.19% 54.68% 54.68%
Inventory $56.89M $55.47M $55.47M
Prepaid Expenses
Receivables $32.97M $26.23M $26.23M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $98.41M $92.02M $92.02M
YoY Change -0.78% -12.86% -12.86%
LONG-TERM ASSETS
Property, Plant & Equipment $34.39M $28.02M $30.03M
YoY Change 30.28% 6.09% 3.37%
Goodwill $8.189M $8.189M
YoY Change 0.0% 0.0%
Intangibles $18.40M $19.00M
YoY Change -9.26% -8.61%
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Long-Term Assets $60.98M $57.22M $57.22M
YoY Change 4.62% -2.65% -2.65%
TOTAL ASSETS
Total Short-Term Assets $98.41M $92.02M $92.02M
Total Long-Term Assets $60.98M $57.22M $57.22M
Total Assets $159.4M $149.2M $149.2M
YoY Change 1.21% -9.21% -9.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.907M $12.10M $12.10M
YoY Change -25.38% 15.1% 15.1%
Accrued Expenses $1.599M $12.39M $11.83M
YoY Change 31.5% 22.97% 33.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $424.0K $419.3K $419.3K
YoY Change 4.69% 3.64% 3.64%
Total Short-Term Liabilities $21.86M $26.01M $26.01M
YoY Change -9.04% 17.56% 17.56%
LONG-TERM LIABILITIES
Long-Term Debt $33.47M $13.10M $23.39M
YoY Change -16.6% -73.75% -61.41%
Other Long-Term Liabilities $4.955M $16.27K $1.043M
YoY Change 657.65% -97.39% -54.78%
Total Long-Term Liabilities $38.43M $13.12M $24.43M
YoY Change -5.79% -74.04% -61.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.86M $26.01M $26.01M
Total Long-Term Liabilities $38.43M $13.12M $24.43M
Total Liabilities $60.29M $51.34M $51.34M
YoY Change -22.06% -39.84% -39.84%
SHAREHOLDERS EQUITY
Retained Earnings $87.79M $86.72M
YoY Change 22.85% 22.19%
Common Stock $13.01M $12.97M
YoY Change 2.29% 2.11%
Preferred Stock
YoY Change
Treasury Stock (at cost) $16.00M $16.00M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $99.09M $97.90M $97.90M
YoY Change
Total Liabilities & Shareholders Equity $159.4M $149.2M $149.2M
YoY Change 1.21% -9.21% -9.21%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $1.636M $11.21M $17.79M
YoY Change 65.25% -1976.52% 486.31%
Depreciation, Depletion And Amortization $860.0K $1.336M $2.957M
YoY Change 19.44% 4.85% 7.03%
Cash From Operating Activities -$10.17M $7.236M $28.90M
YoY Change -232.46% -31.07% 899.38%
INVESTING ACTIVITIES
Capital Expenditures $1.611M $1.202M $4.674M
YoY Change 129.81% 19.62% 8.58%
Acquisitions $750.0K
YoY Change -92.21%
Other Investing Activities $13.15M $12.40M
YoY Change -98327.11% -228.89%
Cash From Investing Activities -$1.611M $11.95M $7.427M
YoY Change 129.81% -1273.13% -152.21%
FINANCING ACTIVITIES
Cash Dividend Paid $561.0K $1.993M
YoY Change 12.88% 4.71%
Common Stock Issuance & Retirement, Net $1.453M
YoY Change 1614.6%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.510M -20.03M -38.44M
YoY Change -192.12% 154.28% -369.26%
NET CHANGE
Cash From Operating Activities -10.17M 7.236M 28.90M
Cash From Investing Activities -1.611M 11.95M 7.427M
Cash From Financing Activities 9.510M -20.03M -38.44M
Net Change In Cash -2.353M -846.6K -2.054M
YoY Change -29.47% -152.85% -174.52%
FREE CASH FLOW
Cash From Operating Activities -$10.17M $7.236M $28.90M
Capital Expenditures $1.611M $1.202M $4.674M
Free Cash Flow -$11.78M $6.034M $24.23M
YoY Change -268.87% -36.44% -1815.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000002098
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
13188617
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
13188617
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-246396
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22734604
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
01-07698
CY2023 dei Entity Registrant Name
EntityRegistrantName
ACME UNITED CORP
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CT
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-0236700
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Waterview Drive
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Shelton
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06484
CY2023 dei City Area Code
CityAreaCode
203
CY2023 dei Local Phone Number
LocalPhoneNumber
254-6060
CY2023 dei Security12b Title
Security12bTitle
$2.50 par value Common Stock
CY2023 dei Trading Symbol
TradingSymbol
ACU
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
77642161
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3645200
CY2023 us-gaap Revenues
Revenues
191500947
CY2022 us-gaap Revenues
Revenues
193962357
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
119290712
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
130403572
CY2023 us-gaap Gross Profit
GrossProfit
72210235
CY2022 us-gaap Gross Profit
GrossProfit
63558785
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59021618
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57285483
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
13188617
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
6273302
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
3096481
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
2396431
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
119317
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
31970
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2977164
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2364461
CY2023 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
12564153
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41002
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-246396
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12523151
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-246396
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22734604
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3662445
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4941444
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
627679
CY2023 us-gaap Net Income Loss
NetIncomeLoss
17793160
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.98
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.86
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2023 us-gaap Net Income Loss
NetIncomeLoss
17793160
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
382312
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-707251
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18175472
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2327515
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4795953
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6100409
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26234421
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32603463
CY2023Q4 us-gaap Inventory Net
InventoryNet
55469992
CY2022Q4 us-gaap Inventory Net
InventoryNet
63325206
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4773464
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2820935
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
750000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
750000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
92023830
CY2022Q4 us-gaap Assets Current
AssetsCurrent
105600013
CY2023Q4 us-gaap Land
Land
2387093
CY2022Q4 us-gaap Land
Land
1979474
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
17501583
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
16614149
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
34704536
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
31491637
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54593212
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
50085260
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26568275
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23669724
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28024937
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26415536
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19001448
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20790535
CY2023Q4 us-gaap Goodwill
Goodwill
8188829
CY2022Q4 us-gaap Goodwill
Goodwill
8188829
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2002272
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2632191
CY2022Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
750000
CY2023Q4 us-gaap Assets
Assets
149241316
CY2022Q4 us-gaap Assets
Assets
164377104
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12101735
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10514288
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1098942
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1130244
CY2023Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
419309
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
404588
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12391998
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10077542
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26011984
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22126662
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13104691
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49915649
CY2023Q4 acu Mortgage Payable Non Current
MortgagePayableNonCurrent
10283988
CY2022Q4 acu Mortgage Payable Non Current
MortgagePayableNonCurrent
10693612
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1026351
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1683323
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
899344
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
305285
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16274
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
622441
CY2023Q4 us-gaap Liabilities
Liabilities
51342632
CY2022Q4 us-gaap Liabilities
Liabilities
85346972
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.5
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.5
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5190072
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3645200
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5083051
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3538179
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12966178
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12698624
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1544872
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1544872
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15995622
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15995622
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15917781
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13447797
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1705587
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2087899
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
86715934
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
70967232
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
97898684
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
79030132
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
149241316
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
164377104
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
77081961
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-707251
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1803302
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1940911
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84715
CY2022 acu Adjustments To Additional Paid In Capital Cash Settlement Of Stock Options
AdjustmentsToAdditionalPaidInCapitalCashSettlementOfStockOptions
108155
CY2022 acu Net Share Settlement Of Stock Options
NetShareSettlementOfStockOptions
218295
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
79030132
CY2023 us-gaap Net Income Loss
NetIncomeLoss
17793160
CY2023 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
13152613
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
750000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-382312
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1940443
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2044458
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1452520
CY2023 acu Adjustments To Additional Paid In Capital Cash Settlement Of Stock Options
AdjustmentsToAdditionalPaidInCapitalCashSettlementOfStockOptions
292153
CY2023 acu Net Share Settlement Of Stock Options
NetShareSettlementOfStockOptions
363273
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
97898684
CY2023 us-gaap Net Income Loss
NetIncomeLoss
17793160
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2023 us-gaap Depreciation
Depreciation
2956513
CY2022 us-gaap Depreciation
Depreciation
2762276
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2111078
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1815508
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1940443
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1803302
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
594059
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-293995
CY2023 acu Non Cash Lease Adjustment
NonCashLeaseAdjustment
-57648
CY2022 acu Non Cash Lease Adjustment
NonCashLeaseAdjustment
-42570
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
171476
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
189874
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-129219
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
199996
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
39405
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
30151
CY2023 acu Fair Value Adjustment Of Earnout Securities Liability
FairValueAdjustmentOfEarnoutSecuritiesLiability
170000
CY2023 acu Payment Of Taxes On Gain On Sale Of Business
PaymentOfTaxesOnGainOnSaleOfBusiness
2907000
CY2022 acu Payment Of Taxes On Gain On Sale Of Business
PaymentOfTaxesOnGainOnSaleOfBusiness
2907000
CY2023 acu Gain Loss On Sale Of Business Net Of Tax
GainLossOnSaleOfBusinessNetOfTax
9644000
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-6329398
CY2022 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1839243
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3648679
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9606835
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
950338
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
173341
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1552352
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1914813
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2374137
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-581449
CY2023 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
11106335
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-143027
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28899495
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2891739
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4673717
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4304264
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
301736
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
300000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9622391
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7427160
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14226655
CY2023 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-36835642
CY2022 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
16848326
CY2023 acu Repayments On Mortgage
RepaymentsOnMortgage
409624
CY2022 acu Repayments On Mortgage
RepaymentsOnMortgage
401410
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
1993049
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
1903346
CY2023 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
292153
CY2022 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
108155
CY2023 acu Payments Of Tax On Net Share Settlement Of Stock Options
PaymentsOfTaxOnNetShareSettlementOfStockOptions
363272
CY2022 acu Payments Of Tax On Net Share Settlement Of Stock Options
PaymentsOfTaxOnNetShareSettlementOfStockOptions
243463
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1452520
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84715
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38441220
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14276667
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60110
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-184691
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2054455
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2757060
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7600409
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4843349
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5545954
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7600409
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5771876
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
978378
CY2023 us-gaap Interest Paid Net
InterestPaidNet
3179184
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2124144
CY2023 acu Business Acquisition Contingent Consideration
BusinessAcquisitionContingentConsideration
750000
CY2022 acu Business Acquisition Contingent Consideration
BusinessAcquisitionContingentConsideration
1330000
CY2023 acu Non Cash Or Part Non Cash Dividends Accrued Not Paid
NonCashOrPartNonCashDividendsAccruedNotPaid
546710
CY2022 acu Non Cash Or Part Non Cash Dividends Accrued Not Paid
NonCashOrPartNonCashDividendsAccruedNotPaid
495406
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. Operations</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The operations of Acme United Corporation (the “Company”) consist of three reportable segments. The operations of the Company are structured and evaluated based on geographic location. The three reportable segments operate in the United States (including Asian operations), Canada and Europe. Principal products across all segments are first aid kits and medical products, scissors, shears, knives, and sharpeners, which are sold primarily to wholesale, contract and retail distributors, office supply super stores, mass market retailers, industrial and medical distributors, school supply distributors, drug store retailers, sporting goods stores, hardware chains and wholesale florists.</span></p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> – The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most sensitive and significant accounting estimates relate to customer rebates, valuation allowances for deferred income tax assets, obsolete and slow-moving inventories, potentially uncollectible accounts receivable, intangibles and stock-based compensation. Actual results could differ from those estimates.</span></p>
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-39410
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-288191
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
567015
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1060812
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
34220635
CY2022 acu Cost Of Goods And Services Sold Shipping And Handling
CostOfGoodsAndServicesSoldShippingAndHandling
11328276
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
CY2023 acu Revenue Milestone Period
RevenueMilestonePeriod
P2Y
CY2023 acu Cost Of Goods And Services Sold Shipping And Handling
CostOfGoodsAndServicesSoldShippingAndHandling
8638865
CY2023 us-gaap Advertising Expense
AdvertisingExpense
1817783
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1563430
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> – The Company performs ongoing credit evaluations of its customers and generally does not require collateral for the extension of credit. Allowances for credit losses are provided and have been within management's expectations. The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023 and 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that individually exceeded 10% of consolidated net sales. Net sales to these customers were approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of consolidated net sales in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p>
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
39315594
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
45371042
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
208212
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
408346
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
15946186
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
17545818
CY2023Q4 us-gaap Inventory Net
InventoryNet
55469992
CY2022Q4 us-gaap Inventory Net
InventoryNet
63325206
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1338211
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1720350
CY2023Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
10007698
CY2022Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
10007698
CY2023Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
18824198
CY2022Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
18502207
CY2023Q4 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
1247536
CY2022Q4 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
1247536
CY2023Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
379921
CY2022Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
379921
CY2023Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2271980
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2271980
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
32731333
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
32409342
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13729885
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11618807
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19001448
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20790535
CY2023Q4 us-gaap Goodwill
Goodwill
8188829
CY2022Q4 us-gaap Goodwill
Goodwill
8188829
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
27190277
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
28979364
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2111078
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1815508
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2270276
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1981863
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1689565
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1361196
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1244529
CY2023Q4 acu Accrued Customer Rebates
AccruedCustomerRebates
5720898
CY2022Q4 acu Accrued Customer Rebates
AccruedCustomerRebates
5533802
CY2023Q4 acu Accrued Contingent Liability Current And Noncurrent
AccruedContingentLiabilityCurrentAndNoncurrent
750000
CY2022Q4 acu Accrued Contingent Liability Current And Noncurrent
AccruedContingentLiabilityCurrentAndNoncurrent
1330000
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
2585124
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
791231
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
546710
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
495406
CY2023Q4 acu Income Taxes Receivable Payable Current And Noncurrent
IncomeTaxesReceivablePayableCurrentAndNoncurrent
362741
CY2022Q4 acu Income Taxes Receivable Payable Current And Noncurrent
IncomeTaxesReceivablePayableCurrentAndNoncurrent
533746
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2442799
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2015798
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
12408272
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
10699983
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2023 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
428047
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
426594
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3405403
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
65263
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
397174
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
192215
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
544251
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
664766
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4346828
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
922244
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
554763
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-238408
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
39853
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-56157
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
594616
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-294565
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4941444
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
627679
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
18984939
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-142095
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
3749665
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
3804540
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22734604
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3662445
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4774267
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
716122
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
612818
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
120922
CY2023 acu Income Tax Reconciliation Stock Options
IncomeTaxReconciliationStockOptions
-385601
CY2022 acu Income Tax Reconciliation Stock Options
IncomeTaxReconciliationStockOptions
-128169
CY2023 acu Income Tax Reconciliation Permanent Items
IncomeTaxReconciliationPermanentItems
183139
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-243179
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-81196
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4941444
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
627679
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2328345
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2004200
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1336996
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1278478
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
609817
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
251655
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4275158
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3534333
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
930000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1170000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1964332
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1687357
CY2023Q4 acu Deferred Tax Assets Asset Valuations
DeferredTaxAssetsAssetValuations
852308
CY2022Q4 acu Deferred Tax Assets Asset Valuations
DeferredTaxAssetsAssetValuations
1109954
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
559174
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
431737
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4305814
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4399048
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
930000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1170000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3375814
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3229048
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
899344
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
305285
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
900000
CY2023Q4 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
SOFR +1.75%
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
13164358000
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
59667000
CY2023Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
51835642000
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
160365
CY2023 acu Revenues Disaggregation By Category
RevenuesDisaggregationByCategory
191501000
CY2022 acu Revenues Disaggregation By Category
RevenuesDisaggregationByCategory
193962000
CY2023 acu Direct Import Sales To Total Net Sales Percentage
DirectImportSalesToTotalNetSalesPercentage
0.06
CY2022 acu Direct Import Sales To Total Net Sales Percentage
DirectImportSalesToTotalNetSalesPercentage
0.08
CY2023 us-gaap Revenues
Revenues
191501000
CY2023Q4 us-gaap Assets
Assets
149241000
CY2023 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
4673000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5011000
CY2022 us-gaap Revenues
Revenues
193962000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
6273000
CY2022Q4 us-gaap Assets
Assets
164377000
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
4305000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4578000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
6273000
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2977000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2364000
CY2023 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
12564000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3662000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.77
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.30
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
24.82
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.83
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1598761
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1138706
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2023 us-gaap Revenues
Revenues
191501000
CY2022 us-gaap Revenues
Revenues
193962000
CY2023 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
292153
CY2022 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
108155
CY2023 acu Issue Of Shares Related To Settlement Of Share Based Compensation
IssueOfSharesRelatedToSettlementOfShareBasedCompensation
20256
CY2022 acu Issue Of Shares Related To Settlement Of Share Based Compensation
IssueOfSharesRelatedToSettlementOfShareBasedCompensation
10067
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1617672
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1537052
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
163500
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
133250
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6938
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6562
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
175473
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
46068
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1598761
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1617672
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1138706
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1132174
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3250
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
166750
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.47
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
29.35
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
20.68
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
31.50
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.95
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.73
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0417
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0279
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.00422
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.00413
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Range Of Dividends Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRangeOfDividendsUsed
1.8%
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Range Of Dividends Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRangeOfDividendsUsed
1.9
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1940443
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1803302
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3539238
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.65
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.14
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
25727340
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1622738
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
20536948
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1565553
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2646835
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
747730
CY2023 us-gaap Net Income Loss
NetIncomeLoss
17793160
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3572144
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3527626
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
85553
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
191624
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3657697
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3719250
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.98
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.86
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
591624
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
296438
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1380648
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-707251
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
382312
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1705587
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4796000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6100000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
750000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
750000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
750000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5546000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7600000
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
1200000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
1344000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1239000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1406000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1281000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
581000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
545000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1177000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
887000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
165000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2229000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
104000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1099000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1026000
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2023 dei Auditor Firm
AuditorFirmId
688

Files In Submission

Name View Source Status
0000950170-24-027907-index-headers.html Edgar Link pending
0000950170-24-027907-index.html Edgar Link pending
0000950170-24-027907.txt Edgar Link pending
0000950170-24-027907-xbrl.zip Edgar Link pending
acu-20231231.htm Edgar Link pending
acu-20231231.xsd Edgar Link pending
acu-ex21.htm Edgar Link pending
acu-ex23_1.htm Edgar Link pending
acu-ex31_1.htm Edgar Link pending
acu-ex31_2.htm Edgar Link pending
acu-ex32_1.htm Edgar Link pending
acu-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
acu-20231231_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending